S1 Episode 2: Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?

24 min•4 april 2023

Om avsnittet

Drs Jeffrey Swigris and Ayodeji Adegunsoye discuss fibrosing interstitial lung disease and treatment challenges for individuals with idiopathic pulmonary fibrosis.

Relevant disclosures can be found with the episode show notes on Medscape (https://www.medscape.com/viewarticle/982422). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.

Resources

Idiopathic Pulmonary Fibrosis (An Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline https://pubmed.ncbi.nlm.nih.gov/35486072/

Health-Related Quality of Life and Symptoms in Patients With IPF Treated With Nintedanib: Analyses of Patient-Reported Outcomes From the INPULSIS® Trials https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990488/

Acute Exacerbation of Idiopathic Pulmonary Fibrosis: A Clinical Review https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089322/

S1 Episode 2: Idiopathic Pulmonary Fibrosis: Who Gets an Antifibrotic?

Om avsnittet

Fler avsnitt

S2 Episode 6: Genetics of Pulmonary Fibrosis: What Is Known and What's to Come?

S2 Episode 5: Managing Complex Patients With Pulmonary Hypertension and ILD

S2 Episode 4: Pulmonary Fibrosis Foundation: How Patient Advocacy Is Transforming IPF Research and Care

S2 Episode 3: Understanding the Role of Circadian Rhythms in Idiopathic Pulmonary Fibrosis

S2 Episode 2: How to Integrate Palliative Care into IPF Treatment Plans

S2 Episode 1: Considerations Around Supplemental Oxygen for Patients With IPF

S1 Episode 6: Now Unfolding: The Future of Idiopathic Pulmonary Fibrosis

S1 Episode 5: Oxygen and Idiopathic Pulmonary Fibrosis: The Experts Advise

S1 Episode 4: How to Cut IPF Symptom Distress

S1 Episode 3: Artful Telemedicine in Idiopathic Pulmonary Fibrosis Care